beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells

Citation
N. Schaschke et al., beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells, BIOORG MED, 10(7), 2000, pp. 677-680
Citations number
14
Categorie Soggetti
Chemistry & Analysis
Journal title
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
ISSN journal
0960894X → ACNP
Volume
10
Issue
7
Year of publication
2000
Pages
677 - 680
Database
ISI
SICI code
0960-894X(20000403)10:7<677:BPCNDT>2.0.ZU;2-R
Abstract
beta-Cyclodextrin is known to form inclusion complexes with hydrophobic dru gs. Several tumor cell lines are known to secrete and/or contain membrane-a ssociated cathepsin B which is possibly involved in invasion and metastasis . Based on these informations. our recently developed endo-epoxysuccinyl pe ptide inhibitor MeO-Gly-Gly-Leu-(2S,3S)-tEps-Leu-Pro-OH for cathepsin B was conjugated with beta-cyclodextrin to obtain a site-directed drug carrier s ystem. Furthermore, the conjugate was shown to form an inclusion complex wi th the cytotoxic drug methotrexate. (C) 2000 Elsevier Science Ltd. All righ ts reserved.